- Home
- ADAM vs NPCE Comparison
ADAM vs NPCE Comparison
Compare ADAM & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAM | NPCE |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.9M | 514.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ADAM | NPCE |
|---|---|---|
| Price | $8.76 | $16.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $8.25 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 796.7K | 270.1K |
| Earning Date | 02-18-2026 | 03-03-2026 |
| Dividend Yield | ★ 10.54% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $216,781,000.00 | $94,864,000.00 |
| Revenue This Year | $11.01 | $24.82 |
| Revenue Next Year | $41.33 | $0.77 |
| P/E Ratio | $45.07 | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $5.02 | $7.56 |
| 52 Week High | $8.76 | $18.98 |
Technical Indicators
Market Signals| Indicator | ADAM | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 58.95 |
| Support Level | N/A | $15.68 |
| Resistance Level | N/A | $17.90 |
| Average True Range (ATR) | 0.00 | 0.94 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 69.78 |
Price Performance
Historical ComparisonAbout ADAM Adamas Trust Inc.
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing and managing primarily mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit sensitive single-family and multi-family assets.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.